ArticleJournal of virology2022

Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories.

Johnny Malicoat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.